Regulation On Expenses For Official Acts Of The Federal Authorities Under The Chemicals Act

Original Language Title: Verordnung über Kosten für Amtshandlungen der Bundesbehörden nach dem Chemikaliengesetz

Read the untranslated law here: http://www.gesetze-im-internet.de/chemkostv_1994/BJNR211800994.html

Regulation on the cost of official acts of the federal authorities under the chemicals Act (chemicals costs regulation ChemKostV) ChemKostV Ausfertigung date: 16.08.1994 full quotation: "chemicals cost regulation as amended by the notice of 23 May 2014 (BGBl. I p. 591)" V go up. by article 4 para 102 in conjunction with art. 5 para 3 G v. 7.8.2013 I 3154 mWv 14.8.2018 stand: Neugefasst by BEK. v. 23.5.2014 I 591 for details on the stand number you see in the menu see remarks footnote (+++ text detection from: 25.8.1994 +++) (+++ explicit note of the legislature on EC law: implementation of EGRL 8/98 (CELEX Nr: 31998 L 0008) cf. V v. 1.7.2002 I 2440 implementation of EC 1907/2006 (CELEX Nr: 32006R1907) see G v. 20.5.2008 I 922 implementation of EGRL 121 / 2006 (CELEX Nr: 32006 L 0121) see G v. 20.5.2008 I 922 EGRL 24/98 (CELEX Nr)) : 31998 L 0024) see G v. 20.5.2008 I 922 +++) § 1 fees (1) the Federal Institute for occupational safety and health charges for individually attributable public services, which are taken as the Federal Office for chemicals under the chemicals Act, subject to the rates of 2 and 3 fees according to the attached schedule of fees. The Robert Koch Institute and the Federal Office of consumer protection and food safety charge in accordance with their respective competences according to section 12a paragraph 3 Nos. 1 and 2 of the chemicals Act of exception approvals referred to in article 55 paragraph 1 subparagraph 1 of Regulation (EU) No. 528 / 2012 of the European Parliament and of the Council of May 22, 2012, through the making available on the market and use of biocidal products (OJ OJ L 167 of the 27.6.2012, p. 1) fees referred to in point 1.8.5 of the fees. The Federal Institute for risk assessment will b paragraph 2 No. 3 of the chemicals Act fee for issuing certificates to good laboratory practice according to § 19 referred to in point 2.1 of the fees. In the rates the expenses are included, according to § 23 paragraph 6 sentence 2 of the German fees Act in conjunction with article 10 paragraph 1 number 1, 2, 4, 7 and 8 of the administrative expenses Act unless otherwise stated from the list of charges.
(2) an individually attributable public performance, for in the list of charges a fixed rate is, in some cases requires exceptional effort, so the fee can be increased up to twice this rate.
(3) requires an individually attributable public performance, for in the list of charges a rate is provided, requires less work than editing a form, because the approval or release documents transmitted electronically or on a magnetic disk, the fee up to 500 EUR can be reduced.

§ 2 (dropped out) section 3 fee on application by the debtor of fees may be granted a fee or a fee waiver if the placing on the market of the substance or biocidal product there is a particular public interest and the applicant cannot expect economic benefits reasonable fees and the development effort.

§ 4 revocation and withdrawal in cases of revocation or the withdrawal of a bureaucracy as well as the rejection or the withdrawal of an application for making an individually attributable public performance fees be accordance of § 23 paragraph 5 sentence 1 and 2 of federal fees law.

§ Are not charged fees and expenses 5 opposition proceedings for opposition proceedings against an administrative act issued by the competent federal authority under this Act.

Section 6 transitional arrangements this Regulation applies to some individually attributable public services application that already have been applied or started from 1 September 2013 but not yet fully delivered until April 30, 2014. For the collection of fees and costs for individually attributable public performance that was requested or started before 1 September 2013 but not yet provided, the chemicals cost regulation in the version applicable up to August 31, 2013 is continue to apply. In cases of the set 2, where the authorisation of a biocidal product no. 528 / 2012 already no. 528 / 2012 according to article 91 of Regulation (EU) according to Regulation (EU), find the fees was referred to in point 4 of the fees of the chemicals cost regulation in application corresponding to the version applicable up to 31 August 2013.

Plant (to § 1 paragraph 1) schedule of fees (site: BGBl. I, 2014, 593-597) fees No. fees facts fee in euro 1 procedure of Regulation (EU) No. 528 / 2012 according to section 12a paragraph 3 and article 12 b ChemG 1.1 EU active ingredient permits 1.1.1 review an application for approval of an active substance referred to in article 8 or the receipt of an application for a EU regulation referred to in article 28 (5) of Regulation (EU) No. 528 / 2012 , possibly plus additional fee after no. 1.1.2 189 800 1.1.2 additional fee for each additional product type approval of an active substance according to no. 1.1.1 47 500 1.1.3 on review of an application for renewal of the approval of an active substance according to article 14 of Regulation (EU) No. 528 / 2012, of a comprehensive assessment is required, if necessary plus additional fee after no. 1.1.4 94 900 1.1.4 surcharge for each additional product type in the renewal of the approval of an active substance according to no. 1.1.3 15 800 1.1.5 review an application for renewal of the approval of an active substance according to article 14 of Regulation (EU) No. 528 / 2012, at which no comprehensive assessment is required, if necessary plus additional fee after no. 1.1.6 47 500 1.1.6 surcharge for each additional product type in the renewal of the approval of an active substance according to no. 1.1.5 15 800 1.2 national product approvals 1.2.1 national authorisation referred to in article 29 of the Regulation (EU) No. 528/2012 a) a biocidal product , if necessary plus additional fees per no. 1.9 50 000 b) a biocidal product family, possibly plus additional fees per no. 1.9 75 000 1.2.2 national authorisation referred to in article 29 of the Regulation (EU) No. 528/2012 a) a biocidal product that is identical to the reference product, which has been evaluated for the active ingredient approval 14 300 b) rated a biocidal product family, which is identical to the reference product family that for the active substance approval was provisional authorisation 19 600 1.2.3 pursuant to article 55 (2) of Regulation (EU) No. 528/2012 a) a biocidal product , possibly plus additional fees per no. 1.9 55 000 b) a biocidal product family, possibly plus additional fees per no. 1.9 82 500 1.2.4 provisional authorisation referred to in article 55 (2) of Regulation (EU) No. 528/2012 a) a biocidal product that is identical to the reference product, which has been evaluated for the active ingredient approval 19 300 b) evaluated a biocidal product family, which is identical to the reference product family, which for the active ingredient approval was national approval 27 100 1.2.5 pursuant to article 29 of the Regulation (EU) No. 528 / 2012 in conjunction with Article 34 (1) of Regulation (EU) No. 528/2012 a) a biocidal product, if necessary plus additional fees per no. 1.9 50 500 b) a biocidal product family, possibly plus additional fees per no. 1.9 75 750 1.2.6 national authorisation referred to in article 29 of the Regulation (EU) No. 528 / 2012 in conjunction with article 34 (1) of Regulation (EU) No. 528/2012 a) a biocidal product that is identical to the reference product , that evaluated for the active ingredient approval was 14 800 b) a biocidal product family, which is identical to the reference product line, which was rated for the active ingredient approval 20 300 1.2.7 renewal of a national authorisation under article 31 of Regulation (EU) No 528 / 2012, of a comprehensive assessment is required. (In the case of a) a biocidal product 50 000 b) a biocidal product family 75 000 1.2.8 renewal of a national authorisation referred to in article 31 of Regulation (EU) No. 528 / 2012, at which no comprehensive assessment is required. In the case of a) a biocidal product 25 000 b) a biocidal product family 37 500 1.2.9 registration of a biocidal product no. 528 / 2012 belonging to a biocidal product family under article 17 (6) of Regulation (EU) 1 200 1.3 simplified product approvals 1.3.1 simplified authorisation to article 26 of Regulation (EU) No. 528/2012 a) a biocidal product 13 400 b) a biocidal product family 20 100 1.3.2 registration after article 27 paragraph 1 of the Regulation (EU) No. 528 / 2012 of deployment on the market a) one after authorised biocidal product authorisation procedures simplified 200 1b which) a biocidal product family approved under the simplified authorisation procedure 1 800 1.3.3 extension a simplified marketing authorisation a) a biocidal product 6 700 b) a biocidal product family 10 100 1.4 approval one same biocidal product 1.4.1 approval pursuant to a regulation under article 17 (7) of Regulation (EU) No. 528/2012 a) a same biocidal product 1 200 b) a same biocidal product family 1 800 1.5 mutual recognitions 1.5.1 approval by means of mutual recognition pursuant to article 33 paragraph 1 , Article 34 paragraph 2 or article 39 of Regulation (EU) No. 528/2012 a) a biocidal product 15 500 b) a biocidal product family 23 300 1.5.2 extension of mutual recognition under article 33 paragraph 1 or article 34 (2) of Regulation (EU) No. 528/2012 a) a biocidal product 3 500 b) a biocidal product family 5 300 1.6 Union approvals 1.6.1
Assessment of the application for Union approval referred to in article 44 of Regulation (EU) No. 528/2012 a) a biocidal product, if necessary plus additional fees per no. 1.9 60 000 b) a biocidal product family, possibly plus additional fees per no. 1.9 90 000 1.6.2 review an application on Union approval according to article 44 of Regulation (EU) No. 528/2012 a) a biocidal product that is identical to the reference product, which has been evaluated for the active ingredient approval 28 500 b) a biocidal product family , which identical to the reference product family, rated for the active ingredient approval 1.6.3 was 42 700 review a request for preliminary approval of the Union pursuant to article 44 of Regulation (EU) No. 528/2012 a) a biocidal product, if necessary plus additional fees per no. 1.9 65 000 b) a biocidal product family, possibly plus additional fees per no. 1.9 97 500 1.6.4 assess an application to preliminary Union approval under article 44 in conjunction with article 55 (2) of Regulation (EU) No. 528/2012 a) a biocidal product , which is identical to the reference product, which has been evaluated for the active ingredient approval 33 500 b) a biocidal product family, which is identical to the reference product line, which was rated for the active ingredient approval 50 200 1.6.5 review an application for renewal of the authorisation of the Union pursuant to article 45 of Regulation (EU) No 528 / 2012, of a comprehensive assessment is required. (In the case of a) a biocidal product 60 000 b) a biocidal product family 90 000 1.6.6 review an application for renewal of the authorisation of the Union referred to in article 45 of Regulation (EU) No. 528 / 2012, at which no comprehensive assessment is required. (In the case of a) a biocidal product 30 000 b) a biocidal product family 45 000 1.7 changes of national product approvals, Union approvals and mutual recognitions 1.7.1 amend an authorisation pursuant to article 50 of Regulation (EU) No. 528 / 2012, at the administrative changes are required. (In the case of a) a biocidal product 350B) a biocidal product family 530 1.7.2 amend an authorisation pursuant to article 50 of Regulation (EU) No. 528 / 2012, at the minor changes are required, unless the Federal Bureau for chemicals the change according to the implementing Act No. 528 / 2012 assessed pursuant to article 51 of Regulation (EU). (In the case of a) a biocidal product 3 800b) a biocidal product family 5 700 1.7.3 amend an authorisation pursuant to article 50 of Regulation (EU) No. 528 / 2012, at the substantial changes are required, unless the Federal Bureau for chemicals the change according to the implementing Act No. 528 / 2012 assessed pursuant to article 51 of Regulation (EU). (In the case of a) a biocidal product 37 100 b) a biocidal product family 55 700 1.7.4 change Union authorised pursuant to article 50 of Regulation (EU) No. 528 / 2012, at the substantial changes are required, unless the Federal Bureau for chemicals the change according to the implementing Act No. 528 / 2012 assessed pursuant to article 51 of Regulation (EU). (In the case of a) a biocidal product 37 100 b) a biocidal product family 55 700 1.7.5 amend an authorisation pursuant to article 50 of Regulation (EU) No. 528 / 2012, with the minor changes are required, provided that the implementing act according to article 51 of Regulation (EU) No. 528 / 2012 no own assessment is carried out by the Federal Office for chemicals. (In the case of a) a biocidal product 350B) a biocidal product family 530 1.7.6 amend an authorisation pursuant to article 50 of Regulation (EU) No. 528 / 2012, at the substantial changes are required, provided that the implementing act according to article 51 of Regulation (EU) No. 528 / 2012 no own assessment is carried out by the Federal Office for chemicals. (In the case of a) a biocidal product 3B 800) a biocidal product family 5 1.8 700 other requests and messages 1.8.1 the admissibility one after article 56 (2) of Regulation (EU) No. 528 / 2012 to report experiment or trial 2 900 1.8.2 the parallel trade permit for article 53 (1) of Regulation (EU) No. 528 / 2012 230 1.8.3 approval of application to confidential treatment of data according to article 66 (4) of Regulation (EU) No. 528 / 2012 , per information 120 1.8.4 exhibition a movement ability certificate 120 1.8.5 exception approval referred to in article 55 paragraph 1 subparagraph 1 of Regulation (EU) No. 528 / 2012 or according to § 12 g paragraph 3 ChemG 2 500 1.9 additional charges for product approvals after no. 1.2.1 or no. 1.6.1 1.9.1 ever further contained active ingredient a) in a biocidal product 4 000 b) in a biocidal product family 6 000 1.9.2 of according another product type a) a biocidal product 4 000 b) a biocidal product family 6 000 1.9.3 of per another user category a) a biocidal product 4 000 b) a biocidal product family 6 000 1.9.4 comparative evaluation ever included active ingredient a) in a biocidal product 10 000 b) in a biocidal product family 15 000 1.9.5 cooperation in determining residue limits referred to in article 19 paragraph 7 of the Regulation (EU) No. 528/2012 a) a biocidal product 5 000 b) a biocidal product family of 7 500 2 other individually attributable public services 2.1 exhibition a confirmation of good laboratory practices pursuant to § 19B paragraph 2 number 3 ChemG 78 per working hour of a GLP Inspector;
a maximum of 25 000 2.2 procedure of Regulation (EU) No. 649 / 2012 of the European Parliament and of the Council of 4 July 2012 on the import of dangerous chemicals (OJ L 201 of the 27.7.2012, p. 60) in accordance with article 21, paragraph 2, sentence 2 ChemG 2.2.1 checking and forwarding an export notification pursuant to article 8 paragraph 2 or 4 of the Regulation (EU) No. 649 / 2012 to the European Commission, unless the substance in annex I part 1 of this regulation is listed 100 2.2.2 testing and forwarding an export notification pursuant to article 8 paragraph 2 or 4 of the Regulation (EU) No. 649 / 2012 to the European Commission , unless the substance in addition Annex I part 2 or 3 of this regulation is listed in 250